AAIPharma takes new name – ZeeCro – after selling off drug development division
AAIPharma
Related Blog Posts
On The Web
Site Search
Get the latest news alerts: Follow LTW at Twitter.
Local Tech Wire
CARY, N.C. – Contract research organization AAIPharma has a new name and a streamlined focus.
ZeeCro is the new name.
The company is now focused on CRO services to life science companies worldwide after having sold its pharmaceutical development services business. The deal included use of the AAIPharma name.
Water Street Healthcare Partners, a private equity firm based in Chicago, bought the drug development group. Financial terms weren’t disclosed.
Operating as AAIPharma Services Corp., the company remains based in Wilmington. It employs some 450 people. Water Street said it would invest $75 million to expand the operation.
ZeeCro offers:
• Integrated early development services (EU)
• Pharmaceutical analysis (EU)
• Clinical trial supplies (EU, SA)
• Phase 1 (EU)
• Bioanalysis(NA & EU)
• Global clinical development services
• Oncology development consulting
The company has operations in North and South America, Europe and South Africa.
Featured
E-mail Preferences
The Skinny
- Will RTP-based ChannelAdvisor go public? They're thinking
- What brands are winning Super Bowl hype? Two Durham firms to find out
- In Super Bowl of social media, Patriots win, Triangle firm says
- Big job cuts coming at IBM? Don't be surprised
- Erskine Bowles is among those who can cash in big time on Facebook IPO
- Ignore Facebook hype - Check out 'risk factors,' too
- Facebook vs. Google IPO: Which deal ranks better?
- Triangle StartUp Factory says business already booming
- Entrepreneurship remains at heart of Tech Wire mission
- Flashback: Tech Wire launched 10 years ago today